Evidence map›Paper›PMID 36202789›Full record

ArticleNature communications2022

Endothelial cell cycle state determines propensity for arterial-venous fate.

Nicholas W Chavkin, Gael Genet, Mathilde Poulet, Erin D Jeffery, Corina Marziano, Nafiisha Genet, Hema Vasavada, Elizabeth A Nelson, Bipul R Acharya, Anupreet Kour and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Gene-Specific Endothelial Programs Drive AVM Pathogenesis inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Nicholas W ChavkinDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0001-9058-0245
Gael GenetDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0003-0016-5887
Mathilde PouletDepartment of Medicine, Yale Cardiovascular Research Center Yale University School of Medicine, New Haven, CT, 06520, USA.ORCID 0000-0002-2216-4132
Erin D JefferyDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0001-9511-7719
Corina MarzianoDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Nafiisha GenetDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Hema VasavadaDepartment of Medicine, Yale Cardiovascular Research Center Yale University School of Medicine, New Haven, CT, 06520, USA.
Elizabeth A NelsonDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Bipul R AcharyaDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Anupreet KourRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Jordon AragonDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0003-0997-5819
Stephanie P McDonnellDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Mahalia HubaDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Gloria M SheynkmanDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0002-4223-9947
Kenneth WalshRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.ORCID 0000-0001-7580-2276
Karen K HirschiDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA. kkh4yy@virginia.edu.ORCID 0000-0001-7116-0130
University of Virginia · USYale University · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Multidisciplinary Training in Cardiovascular ResearchT32HL007224 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAMBURG, NAOMI MIRIAM, WAINFORD, RICHARD DAVID · 1985 to 2020
$12.3M
Multi-tissue platform for modeling systemic pathologiesUH3EB025765 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI VUNJAK-NOVAKOVIC, GORDANA · 2019 to 2021
$4.0M
Wnt signaling control of vascular phenotype in obesityR01HL142650 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GOKCE, NOYAN, WALSH, KENNETH · 2019 to 2023
$3.1M
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesisR01HL136314 · NHLBI · UNIVERSITY OF VIRGINIA · PI OWENS, GARY K · 2018 to 2021
$3.0M
Endothelial Cell Cycle State and Cell FateR01HL146056 · NHLBI · UNIVERSITY OF VIRGINIA · PI HIRSCHI, KAREN KEMPER · 2019 to 2022
$2.1M
Hematopoietic stem cell mutations and ischemic cardio-metabolic diseaseR01HL141256 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2019 to 2022
$1.9M
Integrated heart-liver-vascular systems for drug testing in human health and diseUH2EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2012 to 2013
$1.7M
NCI NIH HHS P30 CA044579NHLBI NIH HHS R01 HL136314NHLBI NIH HHS R01 HL141256NHLBI NIH HHS R01 HL142650NHLBI NIH HHS R01 HL146056NHLBI NIH HHS T32 HL007224NHLBI NIH HHS T32 HL007284NIBIB NIH HHS UH2 EB017103NIBIB NIH HHS UH3 EB025765
6 · The paper itself

Abstract

During blood vessel development, endothelial cells become specified toward arterial or venous fates to generate a circulatory network that provides nutrients and oxygen to, and removes metabolic waste from, all tissues. Arterial-venous specification occurs in conjunction with suppression of endothelial cell cycle progression; however, the mechanistic role of cell cycle state is unknown. Herein, using Cdh5-CreER

Indexed as

Endothelial CellsTransforming Growth Factor beta1AnimalsArteriesCell CycleMiceOxygenVeinsOxygenTransforming Growth Factor beta1

Identifiers

PMID36202789
PMCPMC9537338
OpenAlexW4302424671

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.